Terbinafine for Toenails: The Treatment Course and the Later Result

A thick or discolored toenail can make an oral antifungal sound appealing. Before starting terbinafine during GLP-1 treatment, establish what is causing the nail change and which results will be checked after the course ends.

The LION comparison followed patients to week 72

The 1999 double-blind LION study's analysis population included 496 adults with confirmed dermatophyte toenail infection. It compared daily terbinafine for 12 or 16 weeks with intermittent itraconazole over corresponding periods. Its primary endpoint at week 72 was mycological cure: negative microscopy and culture from the target toenail. [1]

For the 12-week regimens, the reported week-72 rates were 75.7% (81/107) with terbinafine and 38.3% (41/107) with intermittent itraconazole. Keep those outcome denominators with the percentages; they are not percentages calculated over all 496 participants. [1]

This was a comparison of specified oral regimens for a confirmed type of fungal infection. It does not rank tablets against every lacquer or laser, or establish treatment for every abnormal nail noticed during GLP-1 use.

A negative fungal test is not a new nail

AAD explains that a toenail may take a year or longer to grow out completely. Discoloration and other visible changes can remain after the fungus clears. It also notes that fungal nail infection can return after treatment. [3]

Record the treatment end date separately from the next nail assessment. Ask how the clinician will distinguish infection that persists from old nail that is still growing out. A photograph can document appearance, but it cannot substitute for the laboratory endpoint used in the trial.

Arrange the liver review before starting

Terbinafine tablets are contraindicated with chronic or active liver disease. The label requires liver tests before prescribing and recommends periodic monitoring. It also identifies drug interactions, so the prescriber needs your full medicine list. [2]

Include your GLP-1 medicine, other prescriptions, nonprescription products and supplements. Ask who will review results and when. Do not omit a medicine because it is unrelated to the toenail.

Do not dismiss taste changes or persistent nausea

The label directs stopping terbinafine and prompt medical review for possible liver-injury symptoms, including persistent nausea, vomiting, poor appetite, fatigue, right upper abdominal pain, yellowing skin or eyes, dark urine or pale stools. Taste or smell disturbances also call for discontinuation. Taste changes can reduce food intake and may persist. [2]

Write down your appetite and any nausea before the first tablet. If symptoms develop, tell the prescriber when they began and what changed. Do not assume a symptom belongs to your GLP-1 medicine because you have experienced something similar before. Read the complete Medication Guide; these are selected precautions.

If topical treatment is being considered, read the efinaconazole cure-rate and timeline review and the ciclopirox nail-care program. Each involves a different regimen and evidence base.

Printed book

How to Keep Your Face on GLP-1

$12.95 + free shipping

Order Now

✓ 30 day money back guarantee

This article provides general education, not a diagnosis or an individual treatment plan. Medication information refers to US sources. Discuss medication, nutrition and cosmetic treatment decisions with qualified clinicians.